MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2022 International Congress

    The Comparison of Constipation scoring system scales between Parkinson’s disease and non-Parkinson’s disease patients with constipation

    K. Methawasin, A. Krittayasingh, P. Chonmaitree, M. Wongwandee, N. Kongsakorn (Nakhon Nayok, Thailand)

    Objective: This study aims to identify differences of constipation symptoms in detail by using the constipation scoring system between PD patients and non-PD patients. Background:…
  • 2022 International Congress

    Real-World Outcomes Using a Novel Directional Lead from a Multicenter DBS Registry for Parkinson’s Disease

    G. Deuschl, R. Jain, J. Wang, M. Barbe, S. Paschen, C. Sik Lee, J. Volkmann, A. Kühn, J. Vesper (Kiel, Germany)

    Objective: In this report, real-world outcomes using Directional Deep Brain Stimulation (DBS) Systems with multiple independent current source control (MICC) for use in managing symptoms…
  • 2022 International Congress

    Multiple system atrophy mimicked by mitochondrial disease.

    L. Diaz-Feliz, P. Garcia-Ruiz (Madrid, Spain)

    Objective: Characterized a case with A3243G mutation in mtDNA tRNALeu, a variant of mitochondrial disease; MELAS, which presents with atypical parkinsonism as Multiple system atrophy.…
  • 2022 International Congress

    Is there a role for safinamide in atypical parkinsonian syndromes?

    A. Silva, M. Rodrigues (Braga, Portugal)

    Objective: To search for possible benefits of safinamide in atypical parkinsonism. Background: Safinamide is a selective reversible monoamine oxidase-B inhibitor with both dopaminergic and glutamatergic…
  • 2022 International Congress

    Month 24 results of a virtual longitudinal, observational study of Parkinson’s disease: The AT-HOME PD cohort

    M. Zafar, J. Soto, E. Baloga, L. Omberg, E. Macklin, P. Snyder, K. Amodeo, T. Meyers, S. Duquette, C. Stevens, K. Lizzaraga, E. Nnadika, A. Sarkar, C. Tarolli, J. Adams, C. Lungu, J. Gottesman, B. Valdovinos, E. Dorsey, L. Mangravite, T. Simuni, M. Schwarzchild, R. Schneider (Rochester, USA)

    Objective: To describe the change in characteristics of Parkinson’s disease (PD) clinical trial participants over 24 months following trial participation in a remote, longitudinal observational…
  • 2022 International Congress

    Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism

    E. Zinoviev, M. Ganapathy, M. Siddiqui (Winston-Salem, USA)

    Objective: To determine efficacy and safety of BTX therapy in patients with medically refractory foot dystonia secondary to Parkinson’s disease (PD) or atypical Parkinsonism (AP)…
  • 2022 International Congress

    Expanding the armamentarium of clinical use of apomorphine in movement disorders.

    S. Bansal, JR. Chai, M. Jog (London, Canada)

    Objective: To demonstrate the use of subcutaneous(SC) apomorphine injections in suspected untreated dopamine responsive conditions. Background: Apomorphine is a dopamine agonist historically used in dopamine…
  • 2022 International Congress

    Screening of REM Sleep Behavior Disorder and the relation with parkinsonism symptoms in the elderly in southern Brazil: a preliminary population-based study

    G. Pereira, N. Soares, E. Moriguchi, J. Senger, M. Sartori, N. Bruscato, C. Bertocchi, L. Netson, R. Almeida, A. Schumacher-Schuh, C. Rieder (Porto Alegre, Brazil)

    Objective: To describe the preliminary screening profile for suspected REM sleep behavior disorders (RBD) and association with parkinsonian symptoms in the elderly in a population-based…
  • 2022 International Congress

    Protective approach targeting NF-kB/ Nrf2 signaling and neuroinflammation using Apigenin in LPS induced Parkinsonism in experimental rats

    S. Singh (Moga, India)

    Objective: 1. Apigenin as a protective strategy to prevent neuroinflammation in PD.2. To find behavioral, neurochemical and histopathological changes in LPS induced PD. Background: Parkinson’s…
  • 2022 International Congress

    Prospective, Multicenter, International Registry of Deep Brain Stimulation for Essential Tremor

    G. Deuschl, R. Schuurman, G. Loret, N. Kovacs, M. Blázquez Estrada, F. Clement, J. Il Lee, L. Chen, R. Jain (Kiel, Germany)

    Objective: This is a new Essential Tremor (ET) patient registry for patients implanted with a multiple-source, constant-current DBS system capable of providing directionality for use…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley